trending Market Intelligence /marketintelligence/en/news-insights/trending/UefailXRvg7bnZ1_zvxCnw2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Crescita subsidiary acquires skincare line from Sanofi

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Crescita subsidiary acquires skincare line from Sanofi

A wholly-owned subsidiary of Crescita Therapeutics Inc. acquired the Alyria skincare line from Sanofi Consumer Health Inc.

The product line, which is sold into medical spas, will complement INTEGA Skin Sciences' Pro-Derm product offering.

Crescita will pay $1.7 million in cash for the product line and pay a royalty over a nine-year period starting in 2020.

Sanofi Consumer Health is a Sanofi unit.